Dr. Daniel Nagasawa, MD

Dr. Nagasawa practices at Neurological Associates Surgery Center in Santa Monica, California.

Dr. Nagasawa's NPI, 1578820536, was assigned on April 16, 2012. Dr. Nagasawa graduated from University of California, Irvine, California College of Medicine in 2012. Dr. Nagasawa's California license number on file is A129098.

Dr. Nagasawa's primary practice is Neurological Associates Surgery Center, at 2811 Wilshire Blvd, Santa Monica, CA 90403 in Los Angeles County. The practice phone is (310) 829-5968.

Dr. Nagasawa's primary practice is Neurological Associates Surgery Center in Santa Monica, California. Dr. Nagasawa is also affiliated with Providence Saint John's Health Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Nagasawa to 2 more hospitals, 2 group practices and clinics, 1 physician office, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nagasawa practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Nagasawa's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Nagasawa is board certified in neurological surgery by the American Board of Neurological Surgery. Dr. Nagasawa has a license on file in California.

Dmand AI lists back and neck pain treatment without fusion, lower back pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Nagasawa treats.

CMS data shows 561 Medicare services from Dr. Nagasawa across 12 procedure codes in 2024, for 230 Medicare patients. Medicare paid $115,550 for them.

CMS counts 230 Medicare patients who saw Dr. Nagasawa in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have arthritis, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nagasawa's median patient age at 60, with 55% women.

In 2024, Dr. Nagasawa wrote 29 Medicare Part D claims for 19 patients. 83% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $198 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.

Dr. Nagasawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nagasawa as offering telehealth. CMS counts 147 procedures of spinal fusion by Dr. Nagasawa, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 39 papers to Dr. Nagasawa, published from 2011 to 2024. 2017 was the busiest year, with 13. The most frequent topics are Brain Neoplasms, Glioblastoma and Antineoplastic Agents. Dr. Nagasawa has published most often in Clin Neurol Neurosurg. Dr. Nagasawa's most frequent co-authors are Isaac Yang, MD, Lawrance Kon-Yip Chung, MD and Andrew Yenphu Yew, MD.

CMS Open Payments shows 158 general payments to Dr. Nagasawa from 29 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 70% of the total. Nuvasive, Inc. paid the most, $2,654.

Dr. Nagasawa graduated from University of California, Irvine, California College of Medicine in 2012. Dr. Nagasawa is a member of CNS.

Dr. Nagasawa is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.